The coronavirus outbreak has touched virtually every aspect of our lives, including our court system. On March 18, a New Jersey state court declared it was delaying proceedings in a case against American International Industries, the parent company for talc-product manufacturer Clubman.
In the lawsuit, two hairdressers, Margaret Lashley and Dwayne Johnson, seek justice for their exposure to asbestos in Clubman brand’s cosmetic talc products they used in a barbershop. The plaintiffs claim that this exposure caused their fatal cancer.
A jury in Johnson & Johnson's home state of New Jersey ordered the health care and cosmetic products giant to pay punitive damages of $750 million in a talc mesothelioma case last week. The verdict comes on top of $37 million in compensatory damages awarded to four plaintiffs who claimed their disease was caused by asbestos-contaminated talc.
A new study appearing in the current edition of the Journal of Occupational and Environmental Medicine may provide plaintiffs in talc litigation the most powerful evidence yet discovered linking asbestos-contaminated talcum powder to mesothelioma.
How much did Johnson & Johnson really know about asbestos contamination of the talc it used in its Baby Powder? A federal grand jury has been impaneled by the US Department of Justice (DoJ) to find an answer to just that question.
A group of 22 women suffering from ovarian cancer caused by asbestos-containing talcum powder were vindicated this week when a St. Louis jury ordered health care products manufacturer Johnson & Johnson to pay nearly $4.7 billion in damages.
Jury Finds Johnson & Johnson, Imerys Liable in Lawsuit Claiming Talcum Powder Caused Mesothelioma Cancer
In a stunning verdict handed down in a federal court in New Jersey, a jury has ordered pharmaceutical giant Johnson & Johnson and its talc supplier, Imerys, to pay $37 million to a 46-year-old man who alleged that his mesothelioma was caused by his regular use of the defendant's talc-containing products over the course of his lifetime. The trial, which ended yesterday, is the most recent bellwether case over allegations that Johnson & Johnson's flagship products, Baby Powder and Shower to Shower, are carcinogenic.
In August, a Los Angeles jury ordered Johnson & Johnson to pay $417 million to 63-year-old Eva Echeverria, a woman who is now in the terminal stage of ovarian cancer due to having used the company's talc-containing Baby Powder since puberty.
Johnson & Johnson Loses Big in Latest Talcum Powder Ovarian Cancer Verdict: Jury Awards $415 Million
This week, Johnson & Johnson was ordered to pay $415 million to a California woman who alleged that her ovarian cancer was caused by the company's talc-containing Baby Powder. Eva Echeverria, now hospitalized and in the final stages of her illness, said she used the product daily for most of her life. She was diagnosed with ovarian cancer in 2007.
Pharmaceutical Industry Lobbyist Requests to be Removed From List of Defendants in Talcum Powder Trials
Defendants in current trials over the link between talcum powder and ovarian cancer include Johnson & Johnson, manufacturer of the most popular baby powder, and Imerys Talc America, supplier of the talc used in the product. However, there has been a third named defendant: the Personal Care Products Council (PCPC). Based in Washington D.C., the PCPC is a trade association and lobbying group, representing over 600 companies that manufacture and distribute personal care products.
Johnson & Johnson Presents “4 Important Facts About the Safety of Talc” – But Are They Really Factual?
As the number of lawsuits over talc-containing Baby Powder continues to grow, manufacturer Johnson & Johnson – once “The Most Trusted Brand in America” – has been fighting back in order to convince the public of the safety of their product. To that end, the J&J corporate website now has a page on “4 Important Facts About the Safety of Talc.” But is the information accurate? What are the facts?